 | • レポートコード：QAF27586 • 出版社/出版日：QYResearch / 2021年5月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、134ページ • 納品方法：Eメール（即日納品） • 産業分類：医薬品 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本市場調査資料では、世界のベンダムスチン市場について種類別（25mg注射、100mg注射、その他）、用途別（慢性リンパ性白血病、多発性骨髄腫、非ホジキンリンパ腫）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・ベンダムスチン市場の概要 ・世界の主要地域別ベンダムスチン市場規模2016-2027 ・主要プレイヤーの競争状況・市場シェア ・世界のベンダムスチン市場規模2016-2021：種類別（25mg注射、100mg注射、その他） ・世界のベンダムスチン市場予測2012-2027：種類別（25mg注射、100mg注射、その他） ・世界のベンダムスチン市場規模2016-2021：用途別（慢性リンパ性白血病、多発性骨髄腫、非ホジキンリンパ腫） ・世界のベンダムスチン市場予測2012-2027：用途別（慢性リンパ性白血病、多発性骨髄腫、非ホジキンリンパ腫） ・ベンダムスチンのアメリカ市場規模と予測2016-2021 ・ベンダムスチンのヨーロッパ市場規模と予測2016-2021 ・ベンダムスチンの中国市場規模と予測2016-2021 ・ベンダムスチンの日本市場規模と予測2016-2021 ・ベンダムスチンの東南アジア市場規模と予測2016-2021 ・ベンダムスチンのインド市場規模と予測2016-2021 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Teva、Eisai、Eagle Pharmaceuticals、MundiPharma、Mylan、Natco Pharma、Emcure、Miracalus Pharma） ・ベンダムスチンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・ベンダムスチンの市場動向・機会・課題 ・調査の結論 |
Bendamustine is a chemotherapy medication used in the treatment of chronic lymphocytic leukemia (CLL), multiple myeloma, and non-Hodgkin’s lymphoma. It is given by injection into a vein.
Market competition is intense. Teva, Eisai, Eagle Pharmaceuticals, MundiPharma, Mylan, Natco Pharma, Emcure, etc. are the leaders of the industry, with Teva occupies the major markets share of over 83% in 2018.
Market Analysis and Insights: Global Bendamustine Market
The global Bendamustine market was valued at US$ 792.3 in 2020 and will reach US$ 750.5 million by the end of 2027, growing at a CAGR of -0.9% during 2022-2027.
Global Bendamustine Scope and Market Size
The global Bendamustine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Bendamustine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
25mg Injection
100mg Injection
Others
The classification of Bendamustine includes 25mg injection, 100mg injection and other and the proportion of 25mg injection in 2018 is about 64.9%.
Segment by Application
Chronic Lymphocytic Leukemia
Multiple Myeloma
Non-Hodgkin’s Lymphoma
The proportion used in Non-Hodgkin’s Lymphoma occupied the major market share, with about 44.5% in 2018.
The Bendamustine market is analysed and market size information is provided by regions (countries). Segment by Application, the Bendamustine market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Teva
Eisai
Eagle Pharmaceuticals
MundiPharma
Mylan
Natco Pharma
Emcure
Miracalus Pharma
1 Bendamustine Market Overview
1.1 Bendamustine Product Scope
1.2 Bendamustine Segment by Type
1.2.1 Global Bendamustine Sales by Type (2016 & 2021 & 2027)
1.2.2 25mg Injection
1.2.3 100mg Injection
1.2.4 Others
1.3 Bendamustine Segment by Application
1.3.1 Global Bendamustine Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Chronic Lymphocytic Leukemia
1.3.3 Multiple Myeloma
1.3.4 Non-Hodgkin’s Lymphoma
1.4 Bendamustine Market Estimates and Forecasts (2016-2027)
1.4.1 Global Bendamustine Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Bendamustine Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Bendamustine Price Trends (2016-2027)
2 Bendamustine Estimates and Forecasts by Region
2.1 Global Bendamustine Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Bendamustine Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Bendamustine Sales Market Share by Region (2016-2021)
2.2.2 Global Bendamustine Revenue Market Share by Region (2016-2021)
2.3 Global Bendamustine Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Bendamustine Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Bendamustine Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Bendamustine Estimates and Projections (2016-2027)
2.4.2 Europe Bendamustine Estimates and Projections (2016-2027)
2.4.3 China Bendamustine Estimates and Projections (2016-2027)
2.4.4 Japan Bendamustine Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Bendamustine Estimates and Projections (2016-2027)
2.4.6 India Bendamustine Estimates and Projections (2016-2027)
3 Global Bendamustine Competition Landscape by Players
3.1 Global Top Bendamustine Players by Sales (2016-2021)
3.2 Global Top Bendamustine Players by Revenue (2016-2021)
3.3 Global Bendamustine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Bendamustine as of 2020)
3.4 Global Bendamustine Average Price by Company (2016-2021)
3.5 Manufacturers Bendamustine Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Bendamustine Market Size by Type
4.1 Global Bendamustine Historic Market Review by Type (2016-2021)
4.1.1 Global Bendamustine Sales Market Share by Type (2016-2021)
4.1.2 Global Bendamustine Revenue Market Share by Type (2016-2021)
4.1.3 Global Bendamustine Price by Type (2016-2021)
4.2 Global Bendamustine Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Bendamustine Sales Forecast by Type (2022-2027)
4.2.2 Global Bendamustine Revenue Forecast by Type (2022-2027)
4.2.3 Global Bendamustine Price Forecast by Type (2022-2027)
5 Global Bendamustine Market Size by Application
5.1 Global Bendamustine Historic Market Review by Application (2016-2021)
5.1.1 Global Bendamustine Sales Market Share by Application (2016-2021)
5.1.2 Global Bendamustine Revenue Market Share by Application (2016-2021)
5.1.3 Global Bendamustine Price by Application (2016-2021)
5.2 Global Bendamustine Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Bendamustine Sales Forecast by Application (2022-2027)
5.2.2 Global Bendamustine Revenue Forecast by Application (2022-2027)
5.2.3 Global Bendamustine Price Forecast by Application (2022-2027)
6 North America Bendamustine Market Facts & Figures
6.1 North America Bendamustine Sales by Company
6.1.1 North America Bendamustine Sales by Company (2016-2021)
6.1.2 North America Bendamustine Revenue by Company (2016-2021)
6.2 North America Bendamustine Sales Breakdown by Type
6.2.1 North America Bendamustine Sales Breakdown by Type (2016-2021)
6.2.2 North America Bendamustine Sales Breakdown by Type (2022-2027)
6.3 North America Bendamustine Sales Breakdown by Application
6.3.1 North America Bendamustine Sales Breakdown by Application (2016-2021)
6.3.2 North America Bendamustine Sales Breakdown by Application (2022-2027)
7 Europe Bendamustine Market Facts & Figures
7.1 Europe Bendamustine Sales by Company
7.1.1 Europe Bendamustine Sales by Company (2016-2021)
7.1.2 Europe Bendamustine Revenue by Company (2016-2021)
7.2 Europe Bendamustine Sales Breakdown by Type
7.2.1 Europe Bendamustine Sales Breakdown by Type (2016-2021)
7.2.2 Europe Bendamustine Sales Breakdown by Type (2022-2027)
7.3 Europe Bendamustine Sales Breakdown by Application
7.3.1 Europe 134 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 134 Sales Breakdown by Application (2022-2027)
8 China Bendamustine Market Facts & Figures
8.1 China Bendamustine Sales by Company
8.1.1 China Bendamustine Sales by Company (2016-2021)
8.1.2 China Bendamustine Revenue by Company (2016-2021)
8.2 China Bendamustine Sales Breakdown by Type
8.2.1 China Bendamustine Sales Breakdown by Type (2016-2021)
8.2.2 China Bendamustine Sales Breakdown by Type (2022-2027)
8.3 China Bendamustine Sales Breakdown by Application
8.3.1 China 247 Sales Breakdown by Application (2016-2021)
8.3.2 China 247 Sales Breakdown by Application (2022-2027)
9 Japan Bendamustine Market Facts & Figures
9.1 Japan Bendamustine Sales by Company
9.1.1 Japan Bendamustine Sales by Company (2016-2021)
9.1.2 Japan Bendamustine Revenue by Company (2016-2021)
9.2 Japan Bendamustine Sales Breakdown by Type
9.2.1 Japan Bendamustine Sales Breakdown by Type (2016-2021)
9.2.2 Japan Bendamustine Sales Breakdown by Type (2022-2027)
9.3 Japan Bendamustine Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Bendamustine Market Facts & Figures
10.1 Southeast Asia Bendamustine Sales by Company
10.1.1 Southeast Asia Bendamustine Sales by Company (2016-2021)
10.1.2 Southeast Asia Bendamustine Revenue by Company (2016-2021)
10.2 Southeast Asia Bendamustine Sales Breakdown by Type
10.2.1 Southeast Asia Bendamustine Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Bendamustine Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Bendamustine Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)
11 India Bendamustine Market Facts & Figures
11.1 India Bendamustine Sales by Company
11.1.1 India Bendamustine Sales by Company (2016-2021)
11.1.2 India Bendamustine Revenue by Company (2016-2021)
11.2 India Bendamustine Sales Breakdown by Type
11.2.1 India Bendamustine Sales Breakdown by Type (2016-2021)
11.2.2 India Bendamustine Sales Breakdown by Type (2022-2027)
11.3 India Bendamustine Sales Breakdown by Application
11.3.1 India Bendamustine Sales Breakdown by Application (2016-2021)
11.3.2 India Bendamustine Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Bendamustine Business
12.1 Teva
12.1.1 Teva Corporation Information
12.1.2 Teva Business Overview
12.1.3 Teva Bendamustine Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Teva Bendamustine Products Offered
12.1.5 Teva Recent Development
12.2 Eisai
12.2.1 Eisai Corporation Information
12.2.2 Eisai Business Overview
12.2.3 Eisai Bendamustine Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Eisai Bendamustine Products Offered
12.2.5 Eisai Recent Development
12.3 Eagle Pharmaceuticals
12.3.1 Eagle Pharmaceuticals Corporation Information
12.3.2 Eagle Pharmaceuticals Business Overview
12.3.3 Eagle Pharmaceuticals Bendamustine Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Eagle Pharmaceuticals Bendamustine Products Offered
12.3.5 Eagle Pharmaceuticals Recent Development
12.4 MundiPharma
12.4.1 MundiPharma Corporation Information
12.4.2 MundiPharma Business Overview
12.4.3 MundiPharma Bendamustine Sales, Revenue and Gross Margin (2016-2021)
12.4.4 MundiPharma Bendamustine Products Offered
12.4.5 MundiPharma Recent Development
12.5 Mylan
12.5.1 Mylan Corporation Information
12.5.2 Mylan Business Overview
12.5.3 Mylan Bendamustine Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Mylan Bendamustine Products Offered
12.5.5 Mylan Recent Development
12.6 Natco Pharma
12.6.1 Natco Pharma Corporation Information
12.6.2 Natco Pharma Business Overview
12.6.3 Natco Pharma Bendamustine Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Natco Pharma Bendamustine Products Offered
12.6.5 Natco Pharma Recent Development
12.7 Emcure
12.7.1 Emcure Corporation Information
12.7.2 Emcure Business Overview
12.7.3 Emcure Bendamustine Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Emcure Bendamustine Products Offered
12.7.5 Emcure Recent Development
12.8 Miracalus Pharma
12.8.1 Miracalus Pharma Corporation Information
12.8.2 Miracalus Pharma Business Overview
12.8.3 Miracalus Pharma Bendamustine Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Miracalus Pharma Bendamustine Products Offered
12.8.5 Miracalus Pharma Recent Development
13 Bendamustine Manufacturing Cost Analysis
13.1 Bendamustine Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Bendamustine
13.4 Bendamustine Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Bendamustine Distributors List
14.3 Bendamustine Customers
15 Market Dynamics
15.1 Bendamustine Market Trends
15.2 Bendamustine Drivers
15.3 Bendamustine Market Challenges
15.4 Bendamustine Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Bendamustine Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Bendamustine Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Bendamustine Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Bendamustine Sales (K Units) by Region (2016-2021)
Table 5. Global Bendamustine Sales Market Share by Region (2016-2021)
Table 6. Global Bendamustine Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Bendamustine Revenue Share by Region (2016-2021)
Table 8. Global Bendamustine Sales (K Units) Forecast by Region (2022-2027)
Table 9. Global Bendamustine Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Bendamustine Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Bendamustine Revenue Share Forecast by Region (2022-2027)
Table 12. Global Bendamustine Sales (K Units) of Key Companies (2016-2021)
Table 13. Global Bendamustine Sales Share by Company (2016-2021)
Table 14. Global Bendamustine Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Bendamustine Revenue Share by Company (2016-2021)
Table 16. Global Bendamustine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bendamustine as of 2020)
Table 17. Global Bendamustine Average Price (USD/Unit) of Key Company (2016-2021)
Table 18. Manufacturers Bendamustine Manufacturing Sites and Area Served
Table 19. Manufacturers Bendamustine Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Bendamustine Sales (K Units) by Type (2016-2021)
Table 22. Global Bendamustine Sales Share by Type (2016-2021)
Table 23. Global Bendamustine Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Bendamustine Price (USD/Unit) by Type (2016-2021)
Table 25. Global Bendamustine Sales Share by Type (2022-2027)
Table 26. Global Bendamustine Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Bendamustine Revenue Share by Type (2022-2027)
Table 28. Global Bendamustine Price (USD/Unit) by Type (2022-2027)
Table 29. Global Bendamustine Sales (K Units) by Application (2016-2021)
Table 30. Global Bendamustine Sales Share by Application (2016-2021)
Table 31. Global Bendamustine Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Bendamustine Price (USD/Unit) by Application (2016-2021)
Table 33. Global Bendamustine Sales (K Units) by Application (2022-2027)
Table 34. Global Bendamustine Sales Share by Application (2022-2027)
Table 35. Global Bendamustine Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Bendamustine Revenue Share by Application (2022-2027)
Table 37. Global Bendamustine Price (USD/Unit) by Application (2022-2027)
Table 38. North America Bendamustine Sales (K Units) by Company (2016-2021)
Table 39. North America Bendamustine Sales Market Share by Company (2016-2021)
Table 40. North America Bendamustine Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Bendamustine Revenue Market Share by Company (2016-2021)
Table 42. North America Bendamustine Sales by Type (2016-2021) & (K Units)
Table 43. North America Bendamustine Sales Market Share by Type (2016-2021)
Table 44. North America Bendamustine Sales by Type (2022-2027) & (K Units)
Table 45. North America Bendamustine Sales Market Share by Type (2022-2027)
Table 46. North America Bendamustine Sales by Application (2016-2021) & (K Units)
Table 47. North America Bendamustine Sales Market Share by Application (2016-2021)
Table 48. North America Bendamustine Sales by Application (2022-2027) & (K Units)
Table 49. North America Bendamustine Sales Market Share by Application (2022-2027)
Table 50. Europe Bendamustine Sales (K Units) by Company (2016-2021)
Table 51. Europe Bendamustine Sales Market Share by Company (2016-2021)
Table 52. Europe Bendamustine Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Bendamustine Revenue Market Share by Company (2016-2021)
Table 54. Europe Bendamustine Sales by Type (2016-2021) & (K Units)
Table 55. Europe Bendamustine Sales Market Share by Type (2016-2021)
Table 56. Europe Bendamustine Sales by Type (2022-2027) & (K Units)
Table 57. Europe Bendamustine Sales Market Share by Type (2022-2027)
Table 58. Europe Bendamustine Sales by Application (2016-2021) & (K Units)
Table 59. Europe Bendamustine Sales Market Share by Application (2016-2021)
Table 60. Europe Bendamustine Sales by Application (2022-2027) & (K Units)
Table 61. Europe Bendamustine Sales Market Share by Application (2022-2027)
Table 62. China Bendamustine Sales (K Units) by Company (2016-2021)
Table 63. China Bendamustine Sales Market Share by Company (2016-2021)
Table 64. China Bendamustine Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Bendamustine Revenue Market Share by Company (2016-2021)
Table 66. China Bendamustine Sales by Type (2016-2021) & (K Units)
Table 67. China Bendamustine Sales Market Share by Type (2016-2021)
Table 68. China Bendamustine Sales by Type (2022-2027) & (K Units)
Table 69. China Bendamustine Sales Market Share by Type (2022-2027)
Table 70. China Bendamustine Sales by Application (2016-2021) & (K Units)
Table 71. China Bendamustine Sales Market Share by Application (2016-2021)
Table 72. China Bendamustine Sales by Application (2022-2027) & (K Units)
Table 73. China Bendamustine Sales Market Share by Application (2022-2027)
Table 74. Japan Bendamustine Sales (K Units) by Company (2016-2021)
Table 75. Japan Bendamustine Sales Market Share by Company (2016-2021)
Table 76. Japan Bendamustine Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Bendamustine Revenue Market Share by Company (2016-2021)
Table 78. Japan Bendamustine Sales by Type (2016-2021) & (K Units)
Table 79. Japan Bendamustine Sales Market Share by Type (2016-2021)
Table 80. Japan Bendamustine Sales by Type (2022-2027) & (K Units)
Table 81. Japan Bendamustine Sales Market Share by Type (2022-2027)
Table 82. Japan Bendamustine Sales by Application (2016-2021) & (K Units)
Table 83. Japan Bendamustine Sales Market Share by Application (2016-2021)
Table 84. Japan Bendamustine Sales by Application (2022-2027) & (K Units)
Table 85. Japan Bendamustine Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Bendamustine Sales (K Units) by Company (2016-2021)
Table 87. Southeast Asia Bendamustine Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Bendamustine Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Bendamustine Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Bendamustine Sales by Type (2016-2021) & (K Units)
Table 91. Southeast Asia Bendamustine Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Bendamustine Sales by Type (2022-2027) & (K Units)
Table 93. Southeast Asia Bendamustine Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Bendamustine Sales by Application (2016-2021) & (K Units)
Table 95. Southeast Asia Bendamustine Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Bendamustine Sales by Application (2022-2027) & (K Units)
Table 97. Southeast Asia Bendamustine Sales Market Share by Application (2022-2027)
Table 98. India Bendamustine Sales (K Units) by Company (2016-2021)
Table 99. India Bendamustine Sales Market Share by Company (2016-2021)
Table 100. India Bendamustine Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Bendamustine Revenue Market Share by Company (2016-2021)
Table 102. India Bendamustine Sales by Type (2016-2021) & (K Units)
Table 103. India Bendamustine Sales Market Share by Type (2016-2021)
Table 104. India Bendamustine Sales by Type (2022-2027) & (K Units)
Table 105. India Bendamustine Sales Market Share by Type (2022-2027)
Table 106. India Bendamustine Sales by Application (2016-2021) & (K Units)
Table 107. India Bendamustine Sales Market Share by Application (2016-2021)
Table 108. India Bendamustine Sales by Application (2022-2027) & (K Units)
Table 109. India Bendamustine Sales Market Share by Application (2022-2027)
Table 110. Teva Corporation Information
Table 111. Teva Description and Business Overview
Table 112. Teva Bendamustine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 113. Teva Bendamustine Product
Table 114. Teva Recent Development
Table 115. Eisai Corporation Information
Table 116. Eisai Description and Business Overview
Table 117. Eisai Bendamustine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 118. Eisai Bendamustine Product
Table 119. Eisai Recent Development
Table 120. Eagle Pharmaceuticals Corporation Information
Table 121. Eagle Pharmaceuticals Description and Business Overview
Table 122. Eagle Pharmaceuticals Bendamustine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 123. Eagle Pharmaceuticals Bendamustine Product
Table 124. Eagle Pharmaceuticals Recent Development
Table 125. MundiPharma Corporation Information
Table 126. MundiPharma Description and Business Overview
Table 127. MundiPharma Bendamustine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 128. MundiPharma Bendamustine Product
Table 129. MundiPharma Recent Development
Table 130. Mylan Corporation Information
Table 131. Mylan Description and Business Overview
Table 132. Mylan Bendamustine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 133. Mylan Bendamustine Product
Table 134. Mylan Recent Development
Table 135. Natco Pharma Corporation Information
Table 136. Natco Pharma Description and Business Overview
Table 137. Natco Pharma Bendamustine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 138. Natco Pharma Bendamustine Product
Table 139. Natco Pharma Recent Development
Table 140. Emcure Corporation Information
Table 141. Emcure Description and Business Overview
Table 142. Emcure Bendamustine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 143. Emcure Bendamustine Product
Table 144. Emcure Recent Development
Table 145. Miracalus Pharma Corporation Information
Table 146. Miracalus Pharma Bendamustine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2016-2021)
Table 147. Miracalus Pharma Description and Business Overview
Table 148. Miracalus Pharma Bendamustine Product
Table 149. Miracalus Pharma Recent Development
Table 150. Production Base and Market Concentration Rate of Raw Material
Table 151. Key Suppliers of Raw Materials
Table 152. Bendamustine Distributors List
Table 153. Bendamustine Customers List
Table 154. Bendamustine Market Trends
Table 155. Bendamustine Market Drivers
Table 156. Bendamustine Market Challenges
Table 157. Bendamustine Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Bendamustine Product Picture
Figure 2. Global Bendamustine Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Bendamustine Sales Market Share by Application in 2021 & 2027
Figure 6. Chronic Lymphocytic Leukemia Examples
Figure 7. Multiple Myeloma Examples
Figure 8. Non-Hodgkin's Lymphoma Examples
Figure 9. Global Bendamustine Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Bendamustine Sales Growth Rate (2016-2027) & (US$ Million)
Figure 11. Global Bendamustine Sales (K Units) Growth Rate (2016-2027)
Figure 12. Global Bendamustine Price Trends Growth Rate (2016-2027) (USD/Unit)
Figure 13. Global Bendamustine Revenue Market Share by Region: 2016 VS 2021
Figure 14. Global Bendamustine Revenue Market Share by Region: 2021 VS 2027
Figure 15. North America Bendamustine Revenue (Million USD) Growth Rate (2016-2027)
Figure 16. North America Bendamustine Sales (K Units) Growth Rate (2016-2027)
Figure 17. Europe Bendamustine Revenue (Million USD) Growth Rate (2016-2027)
Figure 18. Europe Bendamustine Sales (Million USD) Growth Rate (2016-2027)
Figure 19. China Bendamustine Revenue (Million USD) Growth Rate (2016-2027)
Figure 20. China Bendamustine Sales (Million USD) and Growth Rate (2016-2027)
Figure 21. Japan Bendamustine Revenue (Million USD) Growth Rate (2016-2027)
Figure 22. Japan Bendamustine Sales (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Bendamustine Revenue (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Bendamustine Sales (Million USD) Growth Rate (2016-2027)
Figure 25. India Bendamustine Revenue (Million USD) Growth Rate (2016-2027)
Figure 26. India Bendamustine Sales (Million USD) Growth Rate (2016-2027)
Figure 27. Global 5 Largest Bendamustine Players Market Share by Revenue in Bendamustine: 2016 & 2020
Figure 28. Bendamustine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 29. Global Bendamustine Revenue Share by Type (2016-2021)
Figure 30. Global Bendamustine Revenue Growth Rate by Type in 2016 & 2020
Figure 31. Global Bendamustine Revenue Share by Application (2016-2021)
Figure 32. Global Bendamustine Revenue Growth Rate by Application in 2016 & 2020
Figure 33. North America Bendamustine Sales Market Share by Type in 2020
Figure 34. North America Bendamustine Sales Market Share by Application in 2020
Figure 35. Europe Bendamustine Sales Market Share by Type in 2020
Figure 36. Europe Bendamustine Sales Market Share by Application in 2020
Figure 37. China Bendamustine Sales Market Share by Type in 2020
Figure 38. China Bendamustine Sales Market Share by Application in 2020
Figure 39. Japan Bendamustine Sales Market Share by Type in 2020
Figure 40. Japan Bendamustine Sales Market Share by Application in 2020
Figure 41. Southeast Asia Bendamustine Sales Market Share by Type in 2020
Figure 42. Southeast Asia Bendamustine Sales Market Share by Application in 2020
Figure 43. India Bendamustine Sales Market Share by Type in 2020
Figure 44. India Bendamustine Sales Market Share by Application in 2020
Figure 45. Key Raw Materials Price Trend
Figure 46. Manufacturing Cost Structure of Bendamustine
Figure 47. Manufacturing Process Analysis of Bendamustine
Figure 48. Bendamustine Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed